New Enterprise Associates (NEA)
Biotech Investor · 7 portfolio companies
Portfolio
7
Combined Value
$240M
Focus Areas
14
Top Stage
Phase 1
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Third Harmonic Bio | $240M |
| Iaso Bio | — |
| AviadoBio | — |
| Vesper Medical | — |
| Tempus | — |
| Tagworks Pharmaceuticals | — |
| Personal Genome Diagnostics | — |